ICAgen Inc. (ICGN)


Icagen, Inc. is a biopharmaceutical company based in Research Triangle Park, North Carolina, focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. Utilizing its proprietary know-how and integrated scientific and drug development capabilities, Icagen has identified multiple drug candidates that modulate ion channels. The Company is conducting research and development activities, in some cases in collaboration with leading pharmaceutical companies, in a number of disease areas, including epilepsy, pain, inflammation, sickle cell disease and dementia, including Alzheimer's disease.

Contact Information

4222 Emperor Boulevard
Suite 350
Durham, NC 27703

tel: 919-941-5206
fax: 919-941-0813


Investor Relations



Exchange: NASDAQ
Industry: Diagnostic Substances
Market Cap: $69.7M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.